Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
George, you clearly know ZERO about how Buffett chooses stocks.
Please stop embarrassing yourself.
There is no sales or cash flow on the horizon, AVXL is not his type of stock.
When he bought Apple, it was a large global company with $billions in sales.
Stop it already.
Buffet would never invest in AVXL now.
He invests in companies with growing sales and positive cash flow.
Companies with established market positions.
AVXL right now has none of these
MAYBE after approval for Rett AND alz, with sales in the billions, he'd take a look.
Don't post nonsense.
A better question would be to ask why Baker Bros, Fidelity Biotech and similar funds are NOT here.
that is good news from South Korea, which is an advanced manufacturing economy.
however in the USA, we gamble on paper now and wall street writes the rules. shorty is probably safe here as long as he contributes to the campaigns.
bringing back the tried and true uptick rule for shorting is the answer, but neither side will do anything about it, as they are both bought off
Fadiran is likely keep his stock options, getting fully vested on his departure.
Nice retirement bonus for no results.
Pretty well done spin, but not buying it. Fadiran was useless.
“Each PR has been direct and factual.”
including the one listing 6 milestones that would happen by the end of 2022? LOL
For how long has he been saying that they are planning to meet with the FDA?
For almost as long as he has been promising a new rare disease trial, which is three years now.
Ludicrous speed, fast speed, normal speed, slow speed, glacial speed, Missling speed.
Ok, meant Excellence. Where's the beef? ACAD leaving us in the dust.
So the issue of substance is correct, but you rather comment on date trivia? Got it.
Really? Has the AVXL Excellence data been released? I must have missed it.
Didi Avatar trial fail?
Slow meltdown of stock price, no data yet despite Rett month.
Is the Evil One correct?
ACAD in first place now going into the home stretch to get approved.
Trick or treat for Rett kids.
One day left to get out those Rett results in Rett month.
Will AVXL deliver the treats or a rock in the Halloween pumpkins?
Correct: LOL. Anavex is hardly a pump & dump stock
Yes, it is just a dump stock, no pump at all
LOL - Missling's negotiations problems just got a lot more complicated. Partners for 2-73 will be wanting to have 3-71 as part of the deal because 3-71 could well replace 2-73 in a few years.
C'mon quit making me laugh. there are no negotiation problems because there are no negotiations. 273 is/may be from 1-3 year from approval. 371 wont be approved for a decade at Missling speed.
This is an investment, not a cult. I don't think many here understand that.
I'd say amen but people would not understand that properly.
When people keep saying "I'm a believer" while brushing aside management's failure to deliver and data obscurity, they are not viewing this rationally, they are a cultist.
Management has destroyed the stocks value by never delivering on key milestones while pushing mouse studies. That is a warning sign.
Mouse studies. Useless 371 paper. File the Rett NDA already.
80% of shareholder value lost since summer 2021
No, Bas, the biotech indexes did not crash 80%
This stock is special schitt.
Got to be a record for pizzing away shareholder value when everything is supposedly going great.
Phuk
pants?
Anyone remember when these kinds of personal attacks were violations of the TOS?
Fidelity doesnt allow margin, at least last time I looked. Most brokerages dont allow margin on highly speculative stocks.
Golgotha.
Excellence TLD data should be out by now. 2-3 months is all that is needed.
Lack of data on what is supposed to be an easy shot on goal with Rett is creating the impression that the trial failed and helping the shorts.
Management failure to deliver is stunning.
I doubt anyone is buying AVXL on margin. What brokerage would allow it?
Anavex should be able to walk and chew gum at the same time. Other companies can. What is the purpose of the CMO and CSO if they can't take half a day to do a presentation. What the hell are they actually doing, since we know it is not getting data out in a timely manner, filing NDAs, or getting new trials for Parkinsons or the rare new disease started. These people have been paid for years with ZERO output.
Geez... you're sounding more and more like a 'hole every day.
Oh... you are!
We've been strung along with Wolfram, ALS, MS, Parkinsons and of course the new rare disease now for YEARS.
Not to mention extrapolated uses for heart disease, glaucoma, etc.
Nothing produced. Nothing.
Where's the beef?
Here's the logic. First, Dr. M doesn't have to give the presentation. What happened to the chief medical officer, the chief science officer?
Second, if NDA filings were a priority, an NDA for alz should have been filed already.
And dont even go into the issue of getting things accomplished on time
They would have to give a damg about shareholders to do that.
Great info, Frrol, note data takes 2-3 months, not years
I've been here 8 years and my kids have graduated college, Lag
Ready for a reward for my patience.
VC horizon, payoff due